德展健康
(000813)
| 流通市值：67.72亿 | | | 总市值：67.74亿 |
| 流通股本：20.97亿 | | | 总股本：20.97亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 142,633,396.76 | 88,623,591.58 | 396,809,685.19 | 277,500,292.6 |
| 营业收入 | 142,633,396.76 | 88,623,591.58 | 396,809,685.19 | 277,500,292.6 |
| 二、营业总成本 | 195,413,055.78 | 120,004,752.18 | 557,810,924.68 | 334,353,078.61 |
| 营业成本 | 89,705,137.97 | 49,893,740.59 | 173,982,629.51 | 123,294,451.1 |
| 税金及附加 | 5,850,795.96 | 3,509,768.72 | 11,602,778.31 | 7,877,664.07 |
| 销售费用 | 32,403,037.2 | 17,926,055.43 | 82,187,912.14 | 56,210,102.37 |
| 管理费用 | 86,351,021.37 | 38,885,193.1 | 221,958,985.91 | 154,622,739.43 |
| 研发费用 | 28,312,201.04 | 16,805,322.28 | 82,276,358.49 | 29,070,328.37 |
| 财务费用 | -47,209,137.76 | -7,015,327.94 | -14,197,739.68 | -36,722,206.73 |
| 其中:利息费用 | 1,311,539.78 | 657,668.66 | 2,311,876.42 | 1,678,764.28 |
| 其中:利息收入 | 49,162,796.13 | 7,923,324.82 | 17,222,412.68 | 38,846,023.67 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 46,935.06 | 28,534.17 | 81,338.21 | - |
| 加:投资收益 | -1,427,611.6 | 4,818,187.36 | -27,869,182.51 | -13,980,876.41 |
| 资产处置收益 | -8,635.4 | -8,625.05 | 1,378,451.21 | 480.46 |
| 资产减值损失(新) | -3,178,189.5 | -6,101,753.82 | -179,756,793.34 | -318,791.16 |
| 信用减值损失(新) | -11,450,536.25 | -9,419,441.74 | -53,833,498.86 | -9,027,700.98 |
| 其他收益 | 1,588,517.8 | 917,797 | 1,666,444.9 | 3,890,148.77 |
| 四、营业利润 | -67,209,178.91 | -41,146,462.68 | -419,334,479.88 | -76,289,525.33 |
| 加:营业外收入 | 301,546.85 | 286,537.1 | 136,337.01 | 37,134.48 |
| 减:营业外支出 | 694,635.03 | 202,814.78 | 1,223,991.68 | 311,076.59 |
| 五、利润总额 | -67,602,267.09 | -41,062,740.36 | -420,422,134.55 | -76,563,467.44 |
| 减:所得税费用 | 7,705,443.61 | 2,105,182.79 | 1,503,693.41 | 11,973,731.53 |
| 六、净利润 | -75,307,710.7 | -43,167,923.15 | -421,925,827.96 | -88,537,198.97 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -75,307,710.7 | -43,167,923.15 | -421,925,827.96 | -88,537,198.97 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -58,198,571.39 | -34,422,944.68 | -345,420,067.59 | -61,025,357.03 |
| 少数股东损益 | -17,109,139.31 | -8,744,978.47 | -76,505,760.37 | -27,511,841.94 |
| 扣除非经常损益后的净利润 | -59,269,501.73 | -35,389,747.67 | -348,951,085.54 | -64,272,773.87 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.03 | -0.02 | -0.16 | -0.03 |
| (二)稀释每股收益 | -0.03 | -0.02 | -0.16 | -0.03 |
| 八、其他综合收益 | - | - | -60,038,939.79 | - |
| 归属于母公司股东的其他综合收益 | - | - | -60,038,939.79 | - |
| 九、综合收益总额 | -75,307,710.7 | -43,167,923.15 | -481,964,767.75 | -88,537,198.97 |
| 归属于母公司股东的综合收益总额 | -58,198,571.39 | -34,422,944.68 | -405,459,007.38 | -61,025,357.03 |
| 归属于少数股东的综合收益总额 | -17,109,139.31 | -8,744,978.47 | -76,505,760.37 | -27,511,841.94 |
| 公告日期 | 2026-08-29 | 2026-04-25 | 2026-04-25 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |